191 related articles for article (PubMed ID: 26516361)
1. High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer.
Lin Y; Lv F; Liu F; Guo X; Fan Y; Gu F; Gu J; Fu L
J Cancer; 2015; 6(11):1130-9. PubMed ID: 26516361
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].
Zang MF; Zhang YM; Zhi YH; Zhai Z; Zhang M; Gu F; Zhi XC
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1388-92. PubMed ID: 21756809
[TBL] [Abstract][Full Text] [Related]
3. PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
Papadaki C; Sfakianaki M; Lagoudaki E; Giagkas G; Ioannidis G; Trypaki M; Tsakalaki E; Voutsina A; Koutsopoulos A; Mavroudis D; Georgoulias V; Souglakos J
Br J Cancer; 2014 Oct; 111(9):1757-64. PubMed ID: 25233397
[TBL] [Abstract][Full Text] [Related]
4. Targeting PKM2 promotes chemosensitivity of breast cancer cells in vitro and in vivo.
Wang Y; Zhao H; Zhao P; Wang X
Cancer Biomark; 2021; 32(2):221-230. PubMed ID: 34092620
[TBL] [Abstract][Full Text] [Related]
5. [In vitro chemosensitivity test for hepatocellular carcinoma using collagen-gel droplet embedded cultures].
Nakagawa T; Takahashi H; Kamiyama T; Nakanishi K; Takahashi M; Watanabe K; Taguchi K; Tsukahara M; Nakajima H; Kamachi H; Kurauchi N; Kamiyama N; Khor LW; Abumiya K; Matsushita M; Kobayashi H; Todo S
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2145-9. PubMed ID: 15628760
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
Zhu H; Luo H; Zhu X; Hu X; Zheng L; Zhu X
Oncotarget; 2017 Jan; 8(1):1628-1640. PubMed ID: 27911861
[TBL] [Abstract][Full Text] [Related]
7. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
8. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
9. Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer.
Tozuka K; Horiguchi J; Takata D; Rokutanda N; Nagaoka R; Tokiniwa H; Kikuchi M; Satou A; Takei H; Takeyoshi I
Mol Clin Oncol; 2013 Jan; 1(1):93-99. PubMed ID: 24649129
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
11. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
12. A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma.
Hou J; Hong Z; Feng F; Chai Y; Zhang Y; Jiang Q; Hu Y; Wu S; Wu Y; Gao X; Chen Q; Wan Y; Bi J; Zhang Z
BMC Cancer; 2017 Nov; 17(1):729. PubMed ID: 29117859
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
Yavuz BB; Kilinc F; Kanyilmaz G; Aktan M
J Neurooncol; 2023 Dec; 165(3):527-533. PubMed ID: 38010491
[TBL] [Abstract][Full Text] [Related]
14. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic insights with molecular docking and molecular dynamic simulation studies of anticancer drug 5-Fluorouracil targeting human pyruvate kinase m2.
Priyadarshinee M; Dehury B; Mishra S; Jena C; Patra M; Mishra NK; Samanta L; Mallick BC
J Biomol Struct Dyn; 2024 Feb; ():1-13. PubMed ID: 38345048
[TBL] [Abstract][Full Text] [Related]
16. Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients.
Sandström M; Lindman H; Nygren P; Johansson M; Bergh J; Karlsson MO
Cancer Chemother Pharmacol; 2006 Aug; 58(2):143-56. PubMed ID: 16465545
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
18. Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers.
Takamura Y; Kobayashi H; Taguchi T; Motomura K; Inaji H; Noguchi S
Int J Cancer; 2002 Mar; 98(3):450-5. PubMed ID: 11920599
[TBL] [Abstract][Full Text] [Related]
19. Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer.
Wang H; Peng R; Chen X; Jia R; Huang C; Huang Y; Xia L; Guo G
Oncol Lett; 2018 Apr; 15(4):5553-5560. PubMed ID: 29552193
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Li H; Yan M; Wu X; Wang Y; Huang L
Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
